Ranimustine

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Key facts

Ranimustine is a drug catalogued in DrugCentral.

• ATC code: L01AD07 (Nitrosoureas).
• Molecular formula: C10H18ClN3O7; molecular weight 327.72 g/mol.

ATC classification

ATC code	Therapeutic hierarchy
L01AD07	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › ALKYLATING AGENTS › Nitrosoureas

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Ventricular hypokinesia	66.3
Haemolytic anaemia	61.1
Hepatitis B	60.0
Thrombotic microangiopathy	57.0
Febrile neutropenia	52.0

Chemical structure

• Molecular formula: C₁₀H₁₈ClN₃O₇
• Molecular weight: 327.72 g/mol
• CAS number: —
• InChIKey: AHHFEZNOXOZZQA-ZEBDFXRSSA-N
• PubChem CID: 71741

CO[C@H]1O[C@H](CNC(=O)N(CCCl)N=O)[C@@H](O)[C@H](O)[C@H]1O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is the chemical formula of Ranimustine?

Ranimustine has the molecular formula C10H18ClN3O7 and a molecular weight of 327.72 g/mol.

Sources

• DrugCentral drug card 3519 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2105348 — compound record and bioactivity
• PubChem CID 71741 — chemical identifiers
• DrugBank DB13832 — drug record
• FDA UNII RYH2T97J77 — substance identity
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.